Health

Renowned Wellness Expert Dr Jitendra Pokhriyal Returns to The Westin Resort Nusa Dua, Bali as Wellness Ambassador

BALI, Indonesia, May 15, 2024 /PRNewswire/ -- The Westin Resort Nusa Dua, Bali  is delighted to welcome backDr Jitendra Pokhriyal as their Wellness Ambassador after a four-year hiatus. Dr Jitendra, originally from the Himalayas inIndia, previously served ...

2024-05-15 10:00 2148

ESOC 2024: Higher income reduces stroke mortality risk by a third, new study shows

BASEL, Switzerland, May 15, 2024 /PRNewswire/ -- New research, presented today at the 10th European Stroke Organisation Conference (ESOC) 2024, has revealed that high-income individuals have a 32% lower risk of post-stroke mortality. Additionally, those with a higher education have a 26% lower ri...

2024-05-15 06:01 1852

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

GOTHENBURG, Sweden, May 15, 2024 /PRNewswire/ -- Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to heal...

2024-05-15 02:52 1770

Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China

SHANGHAI, May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced that NEFECON®, a delayed rel...

2024-05-14 21:41 2363

IMG Shares 2024 Summer Travel Trends and Top Destinations

* IMG reviewed the travel itineraries of more than 23,000 of its members with upcoming travel plans betweenJune 1st and August 31st of 2024 to determine emerging travel trends this summer. INDIANAPOLIS, May 14, 2024 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insu...

2024-05-14 21:00 1540

HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology

HUB Organoids Holdings B.V. revolutionizes pre-clinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. SAN ANTONIO, May 14, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the organoids landscape and, based on its find...

2024-05-14 20:00 1595

HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols

PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...

2024-05-14 20:00 1796

Pantai Hospital Kuala Lumpur Continues Legacy of Care with Community Health Screening for the Lembah Pantai Community

KUALA LUMPUR, Malaysia, May 14, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur, together with Premier Integrated Labs, Pantai Integrated Rehab, and Twin Tower Medical Centre, and with support from the Breast Cancer Welfare Association Malaysia and AstraZeneca, marked a milestone in their conti...

2024-05-14 19:41 1765

Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions

SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a$15 million Series A funding round led by Seventure Partners ofFrance and Xora Innovation of Singapore. This significant investment underscores the growing re...

2024-05-14 11:24 2152

OrthAlign Launches Lantern® Handheld Technology for Total, Partial, and Revision Knee Arthroplasty in Japan.

IRVINE, Calif., May 14, 2024 /PRNewswire/ -- OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product, Lantern, inJapan. The launch will be driven by its longstanding commercial partner, who have represented OrthAlign in the market since 2013 and s...

2024-05-14 08:00 1685

VISTA Eye Specialist Celebrates Families and Vision with Vibrant Eye Carnival

PETALING JAYA, Malaysia, May 14, 2024 /PRNewswire/ -- VISTA Eye Specialist ('VISTA') is thrilled to announce its upcoming VISTA Parents' Day Eye Carnival ('Eye Carnival'), a celebration of family, wellness, and the gift of sight. This special event, held over two weekends, 24-26 May and 31 May -2...

2024-05-14 08:00 1616

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies

DURHAM, N.C. and BEIJING, May 14, 2024 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced tha...

2024-05-14 07:27 2148

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...

2024-05-13 13:34 1927

SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers

SINGAPORE, May 13, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell receptor-...

2024-05-13 10:00 3206

Saving 70% of water - New Irrigation System Revolutionizes Farming in Tropical Regions

TAIPEI, May 13, 2024 /PRNewswire/ -- After decades of dormancy, irrigation technology has finally received a sustainable upgrade. According to Grand View Research, the global irrigation automation market size to be valued atUSD 8.96 billion by 2027 and is expected to grow at a compound annual gr...

2024-05-13 09:00 1837

RemeGen Celebrates World Lupus Day 2024 with Increased Lupus Visibility through Vital Knowledge Sharing

The biotech company continues to offer hope to systemic lupus erythematosus ( SLE) patients globally by sharing the latest developments of its proprietary novel fusion protein drug Telitacicept YANTAI, China, May 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd.  ("RemeGen" or "t...

2024-05-10 16:26 2364

Diagnostic Imaging for Women Enhances Mammography Quality with AI: Results Presented at ASMIRT 2024

DARWIN, Australia, May 10, 2024 /PRNewswire/ -- At the Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) conference this week in Darwin, Diagnostic Imaging for Women (difw), together with Volpara Health announced significant advancements in applying AI to mammography quality as...

2024-05-10 08:58 1892

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias. Preliminary data of VCAS study will be presented at HRS 2024 in Boston, Mass. CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field M...

2024-05-09 20:03 2345

Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines

Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour biology and vaccine technologies since the pandemic OXFORD, England, May 9, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in pr...

2024-05-09 15:30 2158

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The GHIT Fund inv...

2024-05-09 10:00 1642
1 ... 54555657585960 ... 580

Week's Top Stories